EverHint – Momentum Swing — Breakout Standard for Apr 14, 2026 – 9 Signals – Healthcare Leads (4)

What This Signal Is (Quick)

Breakout Standard is a momentum swing trading strategy focused on Stocks within 3% of 52-week high - standard breakout momentum setups.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

• Stock showing strong momentum near or at highs
• Increased volume confirms institutional interest
• Breaking out or consolidating near resistance
• Stocks within 3% of 52-week high - standard breakout momentum setups

Ideal For: Swing traders looking for breakout opportunities with confirmed momentum

Key Criteria:

• Strong RSI momentum (configurable thresholds)

• Volume surge above average

• Price momentum confirmation

• Minimum ADV: $25M+ (varies by variant)

• Earnings buffer: 7 days pre/post earnings

• Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High

How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)

📊 Momentum Swing — Breakout Standard Signals (9 Total)

Ranked by score:

Field Notes

Sector concentration: Healthcare (4), Technology (3), Communication Services (1)

Insider selling: TVTX (Travere Therapeutics, Inc., $-4.7M), SYRE (Spyre Therapeutics, Inc., $-1.5M), LGND (Ligand Pharmaceuticals Incorporated, $-442K)

Data coverage: 33.3% insider, 11.1% congressional (1 older/1y), 100.0% earnings, 100.0% analyst, 33.3% news

Peer Analysis

Understanding how these stocks relate to their industry peers:

AVNS (Avanos Medical, Inc.): Leads 9 peers: VREX ($11.74, +2.8%), CTKB ($4.62, +0.7%), CLPT ($10.38, +3.7%), PACB ($1.57, +8.3%), CYH ($3.07, +0.3%) | Peer of: BVS ($9.91, +5.2%), CLPT ($10.38, +3.7%), CMPS ($5.75, -0.3%) and 8 more

UI (Ubiquiti Inc.): Leads 10 peers: NOK ($10.35, -0.2%), MPWR ($1363.42, -0.6%), EA ($202.85, +0.1%), TTWO ($205.10, +1.9%), CLS ($384.35, +5.2%) | Peer of: CLS ($384.35, +5.2%), EA ($202.85, +0.1%), FICO ($1007.28, +0.6%) and 8 more

TVTX (Travere Therapeutics, Inc.): Leads 10 peers: CGON ($67.28, -0.6%), TARS ($73.81, +1.6%), CELC ($120.85, +0.4%), XENE ($59.35, +1.3%), CNTA ($39.59, +0.1%) | Peer of: ARQT ($25.09, +4.0%), CELC ($120.85, +0.4%), CGON ($67.28, -0.6%) and 9 more

ECG (Everus Construction Group, Inc.): Leads 10 peers: GVA ($126.98, -0.2%), AGX ($603.91, +0.9%), POWL ($234.42, +2.4%), BCO ($106.66, -0.2%), KBR ($36.36, -1.4%) | Peer of: ACA ($114.24, -0.2%), AGX ($603.91, +0.9%), ALK ($42.62, +6.6%) and 13 more

LGND (Ligand Pharmaceuticals Incorporated): Leads 10 peers: PRAX ($343.60, +8.4%), BLTE ($171.93, -0.7%), MIRM ($96.90, +0.4%), ACAD ($22.02, +2.6%), ADMA ($10.49, +1.1%) | Peer of: ACAD ($22.02, +2.6%), ADMA ($10.49, +1.1%), BLTE ($171.93, -0.7%) and 5 more

SYRE (Spyre Therapeutics, Inc.): Leads 10 peers: PHVS ($28.68, +2.9%), IMNM ($22.90, +1.2%), WVE ($7.39, +1.8%), NTLA ($14.78, +3.6%), ZYME ($26.98, +3.1%) | Peer of: ABCL ($3.76, +2.7%), ARDX ($6.33), AZTA ($24.26, +4.0%) and 12 more

GSAT (Globalstar, Inc.): Leads 6 peers: TKC ($6.42, +0.2%), TDS ($45.49, +0.5%), PHI ($20.65, +0.9%), LUMN ($7.80, +0.1%), MSGS ($339.74, +2.6%) | Peer of: MSGS ($339.74, +2.6%), NXST ($194.11, +5.3%), TKC ($6.42, +0.2%)

CLS (Celestica Inc.): Leads 9 peers: GRMN ($264.47, +1.1%), KEYS ($330.46, -0.2%), FICO ($1007.28, +0.6%), NOK ($10.35, -0.2%), FLEX ($80.14, +2.3%) | Peer of: EA ($202.85, +0.1%), FICO ($1007.28, +0.6%), GLW ($172.77, -1.3%) and 5 more

ADTN (ADTRAN Holdings, Inc.): Leads 9 peers: GILT ($18.73, +2.5%), AOSL ($30.38, +10.9%), NTGR ($24.10, +2.1%), ITRN ($54.70, +0.6%), CRSR ($6.13, +1.8%) | Peer of: AIOT ($3.14, +3.6%), AOSL ($30.38, +10.9%), AUROW ($0.19, +11.1%) and 10 more

Congressional Activity

CLS (Celestica Inc.) 🟢 Bullish (1y)

• 1 purchase by 1 member
• Top buyer: Hou. Cleo Fields (LA) - 1 transaction ($15,001 - $50,000)

Recent Headlines

ADTN (ADTRAN Holdings, Inc.)

• ADTRAN Holdings (ADTN) Surges 7.9%: Is This an Indication of Further Gains? (source)
• Why Adtran Holdings Stock Is Climbing Today (source)
• ProRail strengthens nationwide rail network with Adtran ALM fiber monitoring solution (source)
• Adtran launches Ensemble Cloudlet multi‑node to simplify high‑availability edge AI deployments (source)

AVNS (Avanos Medical, Inc.)

• This Healthcare Stock Is Rising 69%. It's Getting Bought Out for a Big Premium. (source)
• $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avanos Medical, Inc. (NYSE: AVNS) (source)
• Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders (source)
• AVNS Stock Alert: Halper Sadeh LLC is Investigating Whether Avanos Medical, Inc. is Obtaining a Fair Price for its Shareholders (source)
• AIP to take Avanos Medical private in a deal valued at about $1.27 billion (source)
• Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion (source)

TVTX (Travere Therapeutics, Inc.)

• FDA Approval For Travere's Drug Expands Reach To Broader Rare Kidney Disease Patients (source)
• Travere Therapeutics Stock Skyrockets On FDA Approval (source)
• Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS Transcript (source)
• US FDA expands approval for Travere Therapeutics' drug for rare kidney disease (source)
• Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS (source)
• Roy Baynes Sells 10,000 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock (source)
• Aberdeen Group plc Trims Holdings in Travere Therapeutics, Inc. $TVTX (source)

Market Context

Broad market indices are exhibiting solid upward momentum, with the Nasdaq leading gains at +1.94%, followed by the S&P 500 at +1.17% and the Dow at +0.66%. This bullish trend signals strong risk appetite among investors, creating a favorable environment for momentum swing breakout strategies that thrive on sustained directional moves. The VIX's decline to 18.36 (-3.97%) reflects contracting volatility, which tempers extreme intraday swings but still allows for clean breakouts in trending conditions, reducing the risk of false signals from erratic price action.

Lower volatility levels enhance the reliability of swing breakouts by promoting smoother price channels and higher conviction in momentum trades, particularly in an uptrending market. However, traders should monitor for any volatility spikes that could erode edges in shorter-term swings. The divergent index performance hints at sector rotation, with technology-heavy indices outperforming, yet healthcare emerging as the top sector for signals—this suggests defensive rotation within a risk-on backdrop, potentially amplifying breakout opportunities in resilient areas amid broader gains.

Overall, these conditions support the strategy's 9 total signals, as positive trend direction and subdued volatility favor capturing upside swings, though discipline in sector alignment remains key to navigating rotation dynamics.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (4 signals) suggests sector-specific rotation. 3 signals showing insider selling warrant caution.

Sharing Call-to-Action

📊 A simple like, share, or subscribe helps this channel reach more traders who follow data, not noise.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/